FDA
-
-
-
-
-
-
-
Thermo Fisher Scientific to acquire Clario for $8.875 billion
-
-
-
-
-
-
-
Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
-
-
-
-
-
-
-
Thermo Fisher Scientific (TMO) Acquires CorEvitas for $912.5M Cash
-
-
-
-
-
-
-
Mercy BioAnalytics Appoints Dawn Mattoon, PhD, as Chief Operating Officer
-
-
-
-
-
-
-
Thermo Fisher Scientific (TMO) Announces FDA Authorizes New High-Throughput, Automated System for Leading COVID-19 Test
-
-
-
-
-
-
-
Thermo Fisher Scientific and Innoforce Partner to Establish Biologics and Steriles Drug Manufacturing Facility in China
-
-
-
-
-
-
-
Thermo Fisher Scientific to leverage Tecan’s automation technology to enable scaled-up COVID-19 testing globally
-
334,640 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


